Munira Borhany: Moving Beyond Stereotypes in the Diagnosis of Bleeding Disorders
Munira Borhany, Hematologist/hemato‐oncologist at Dr. Ziauddin Hospital and Midciti Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Von Willebrand disease (VWD) is the most common inherited bleeding disorder but remains under-recognised, particularly among women and girls.
In our recently published study of patients treated at Hemophilia Welfare Society Karachi, we evaluated subtype distribution, bleeding severity, and treatment outcomes.
Key findings:
- Type 3 VWD carried the highest clinical burden, with very frequent and severe bleeding.
- Mucocutaneous bleeding, especially gum bleeding, was highly prevalent.
- Joint bleeding significantly affected severe cases.
- 63% of females experienced heavy menstrual bleeding (HMB).
Heavy menstrual bleeding and Iron Deficiency Anemia (IDA) are too often normalised or dismissed. They are not ‘just periods’. They may be the first clinical marker of an inherited bleeding disorder.
Using structured assessment with ISTH-BAT bleeding scores and individualised management, we observed:
- Reduction in annual bleeding rates
- Improvement in hemoglobin levels
- Better joint outcomes
- Enhanced psychological well-being
Bleeding disorders are not only about boys with joint bleeds.
Women bleed too. Girls bleed too.
Early diagnosis – particularly in patients presenting with HMB and IDA – is critical. Comprehensive, gender-sensitive screening and timely treatment are essential to improve outcomes and quality of life, especially in resource-limited LMIC settings.”
Title: Clinical Spectrum, Subtype Distribution, and Treatment Outcomes in von Willebrand Disease: A Prospective Study from a Hemophilia Treatment Center in Pakistan.
Authors: Munira Borhany, Heeba Qureshi, Nida Khurshid Ahmed, Maleeha Umair, Raheel Ahmed
Read the Full Article on Sage Journals.

For more information see the gallery.
Stay updated with Hemostasis Today.
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque
-
May 22, 2026, 16:25Edward Lee Carter: What Is Changing in Antiplatelet Deprescribing and Why It Matters
-
May 22, 2026, 15:02Robert Brodsky: Can You Stop Thrombosis and Treat CAPS Without Anticoagulation?
-
May 22, 2026, 14:50Eric Topol: New Nature Editorial on the Limits and Promise of AI Scientists
-
May 22, 2026, 14:40Harry Spoelstra: Omicron COVID-19 and Coronary Thrombosis Without Atherosclerosis
-
May 22, 2026, 14:21Clinical Challenges in Thrombosis III – Thrombosis Canada